Other Countries
| Title | Link |
|---|---|
| Biotechnology, Ethics and Government: Report to the Interdepartmental Working Group on Ethics - Winter 1998 - (125 pages) | http://strategis.ic.gc.ca/pics/bh/bioteche.pdf |
| Under-valuing Australia’s genetic materials by accepting broad claims in patenting genetic materials under the Patents Act 1990 (Cth) - (75 pages) | http://www.ipcr.gov.au/ipcr/SUBMIS/docs/03lawson.pdf |
| Parallel Importing A Theoretical and Empirical Investigation - Report to Ministry of Commerce - Prepared by NZIER - February 1998 | http://www.med.govt.nz/buslt/int_prop/parallel/index.html#TopOfPage |
| Mattias Ganslandt and Keith E. Maskus - Parallel Imports of Pharmaceutical Products in the European Union - Please do not quote without permission - (27 pages) | http://econ.worldbank.org/files/2240_wps2630.pdf |
| Mattias Ganslandt and Keith E. Maskus - Parallel Imports of Pharmaceutical Products in the European Union - The Research Institute of Industrial Economics - Working Paper No. 546, 2001 - (28 pages) | http://swopec.hhs.se/iuiwop/papers/iuiwop0546.pdf |
| Léo-Paul Lauzon & Marc Hasbani - Analyse socio-économique de l'industrie pharmaceutique brevetée pour la période de dix ans (1991-2000) - Avril 2002 | http://www.unites.uqam.ca/cese/etude24pharm/pharmtab.html |
| Carlos M. Correa - Recent Developments in the Field of Pharmaceutical Patents: Implementation of the TRIPs Agreement - December 1998 | http://www.haiweb.org/campaign/novseminar/correa2.html |
| Report of the Committee on the Drug Review Process of the Science Advisory Board to Health Canada - (17 pages) | http://www.hc-sc.gc.ca/hpb/science/pdf/drg/drug_e.pdf |
| Peter Drahos and John Braithwaite - The Globalisation of Regulation - (26 pages) | http://www.oiprc.ox.ac.uk/EJWP0200.pdf |
| A.S.Taubman - Reorienting TRIPS: Intellectual Property Law in North Asia - Working paper - 2001 | http://www.law.unimelb.edu.au/news/assets/TaubmanPaper.doc |
| Nicholas Gruen & Gerard Prior & Ian Bruce Extending Patent Life: Is it in Australia's Economic Interests ? - June 1996 - (49 pages) | http://www.lateraleconomics.com/outputs/Extending%20Patent%20Life.pdf |
| Ludmila Maksimova - Russian Government Takes Measures to Regulate Pharmaceutical Market - February 1999 | http://www.bisnis.doc.gov/bisnis/isa/9902phar.htm |
| The National Strategy for Quality Use of Medicines - (32 pages) | http://www.health.gov.au/hbd/qum/natstrat.pdf |
| Quality Use of Medicines Statement of Priorities and Strategic Action Plan 2001–2003 - (53 pages) | http://www.health.gov.au/hbd/qum/qumstmt.pdf |
| Australian commonwealth Department of Health and Aged Care - Human Research Ethics Committees and the Therapeutic Goods Legislation - June 2001 - (66 pages) | http://www.health.gov.au/tga/docs/pdf/unapproved/hrec.pdf |
| New Zealand Ministry of Health - Operational Standard for Ethics Committees - March 2002 - (145 pages) | http://www.moh.govt.nz/moh.nsf/c7ad5e032528c34c4c2566690076db9b/ffc06a2c2009deeecc256b9400787b61/$FILE/OperationalStandard_final.pdf |
| New Zealand - Guide on Codes of Ethical Conduct - May 2002 (28 pages) | http://202.78.129.207/biosecurity/animal-welfare/naeac/papers/naeaccec.pdf |
| Productivity Commission 2001 - International Pharmaceutical Price Differences, Research Report, AusInfo, Canberra. - July 2001 - (225 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID277602_code010731670.pdf?abstractid=277602 |
| Brazil, Pharmaceutical Industry and WTO - (87 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID272208_code010605140.pdf?abstractid=272208 |
| Holly Stewart, Vivienne Murray, Premarin The Hidden Costs, Earth Save Canada | http://www.earthsave.bc.ca/materials/articles/art |
| Margaret Duckett, Compulsory Licensing and Parallel Importing: What do they mean? Will they improve access to essential drugs for people living with HIV/AIDS? Background Paper, ICASO, July 1999 | http://www.icaso.org/docs/compulsoryenglish.htm |
| BioIsrael - home page -"the hubsite of Israel`s life sciences community and the leading source of news about Israeli biotechnology and medical device companies" | http://www.bioisrael.com |
| Harvey E. Bale, Consumption and trade in off- patented medicines. ICRIER, Working Paper n° 65 - May, 2001 - (29 pages) | http://www.icrier.res.in/pdf/bale65.PDF |
| John Barton, Differentiated pricing of patented products, ICRIER Working Paper n° 63 - March, 2001 - (27 pages) | http://www.icrier.res.in/pdf/barton63.PDF |
| Co-op with foreign rivals benefit drug makers | http://www1.chinadaily.com.cn/cndy/index.html |
| Cipla - home page | http://www.cipla.com/ |
| Pontifical Academy for life - Declaration on the production and the scientific and therapeutic use of human embryonic stem cells | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_20000824_cellule-staminali_en.html |
| Pontifical Academy for life - statement on the so-called "morning-after pill" | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_20001031_pillola-giorno-dopo_en.html |
| Pontifical Academy for life - Reflections on Cloning | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_30091997_clon_en.html |
| Pontifical Academy for life - identity and Statute of Human Embryos | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_06041998_embrione_en.html |
| Kym Anderson, Chantal Pohl Nielsen and Sherman Robinson - Estimating the Economic Effects of GMOs: the Importance of Policy Choices and Preferences - Policy Discussion Paper No. 0035 -August 2000- Adelaide University - Australia - (40 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID243553_code000925130.pdf?abstractid=243553 |
| Chantal Nielsen and Kym Anderson - GMOs, Trade Policy, and Welfare in Rich and Poor Countries - May 2000 - (43 pages) - Policy Discussion Paper No. 0021 - University of Adelaide - Australia | http://papers.ssrn.com/sol3/delivery.cfm/000602350.pdf?abstractid=231201 |
| Chantal Nielsen and Kym Anderson - Global Market Effects of Alternative European Responses to GMOs - Policy Discussion Paper No. 0032 - University of Adelaide - Australia - (24 pages) | http://papers.ssrn.com/sol3/delivery.cfm/000816360.pdf?abstractid=239451 |
| Cugahi Pharmaceutical - home page - in English | http://www.chugai-pharm.co.jp/ceind02/index.htm |
| Takeda Chemical Industries - home page - in English | http://www.takeda.com/index-e.html |
| Kissei Pharmaceutical (Japan) - home page - in English | http://www.kissei.co.jp/e_contents/from_ceo.htm |
| Fujisawa Pharmaceutical (Japan) - home page - in English | http://www.fujisawa.co.jp/english/index.html |
| Expert Panel on the Future of Food Biotechnology - Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in Canada - February 2001 - (261 pages) | http://www.rsc.ca/foodbiotechnology/GMreportEN.pdf |
| Royal Commission on Genetic Modifications - the Report - New Zealand | http://www.gmcommission.govt.nz/RCGM/rcgm_report.html |
| Patent & Honesty firm - Information about patents in Korea | http://www.hnpat.com/information/e_flow1.htm |
| Pharmabiz - home page - "India's most comprehensive pharma portal" | http://www.pharmabiz.com/ |
| PATSCAN - University of British Columbia - Newsletter and publications | http://www.library.ubc.ca/patscan/ip_news_and_research.html |
| Indian Council for Research on International Economic Relations - ICRIER | http://www.icrier.res.in/index.html |
Last updated: July 7, 2002